Respiratory Medicine
Volume 102, Issue 12 , Pages 1694-1700 , December 2008

Recombinant tissue plasminogen activator in the treatment of pleural infections in adults

  • Marios E. Froudarakis

      Affiliations

    • Department of Pneumonology, Medical School, Democritus University of Thrace, Greece
    • Corresponding Author InformationCorresponding author. Department of Pneumonology, University Hospital of Alexandroupolis, 68100 Alexandroupolis, Greece. Tel./fax: +30 2551075096.
    • ,
  • George Kouliatsis

      Affiliations

    • Department of Pneumonology, Medical School, Democritus University of Thrace, Greece
    • ,
  • Paschalis Steiropoulos

      Affiliations

    • Department of Pneumonology, Medical School, Democritus University of Thrace, Greece
    • ,
  • Stavros Anevlavis

      Affiliations

    • Department of Pneumonology, Medical School, Democritus University of Thrace, Greece
    • ,
  • Athanasia Pataka

      Affiliations

    • Department of Pneumonology, Medical School, Democritus University of Thrace, Greece
    • ,
  • Maria Popidou

      Affiliations

    • Department of Pneumonology, Medical School, Democritus University of Thrace, Greece
    • ,
  • Demitrios Mikroulis

      Affiliations

    • Department of Cardiothoracic Surgery, Medical School, Democritus University of Thrace, Greece
    • ,
  • Ioannis Pneumatikos

      Affiliations

    • Department of Intensive Care, Medical School, Democritus University of Thrace, Greece
    • ,
  • Demosthenes Bouros

      Affiliations

    • Department of Pneumonology, Medical School, Democritus University of Thrace, Greece

Received 20 May 2008 ,Accepted 15 August 2008.

References 

  1. Davies CW, Gleeson FV, Davies RJ. BTS guidelines for the management of pleural infection. Thorax. 2003;58(Suppl. 2):ii18–ii28
  2. Davies W, Kearney S, Gleeson F, Davies R. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med. 2003;160:1682–1686
  3. Strange C, Allen ML, Harley R, Lazarchick J, Sahn SA. Intrapleural streptokinase in experimental empyema. Am Rev Respir Dis. 1993;147:962–966
  4. Bouros D, Schiza S, Siafakas N. Fibrinolytics in the treatment of parapneumonic effusions. Monaldi Arch Chest Dis. 1999;54:258–263
  5. Bouros D, Schiza S, Panagou P, Drositis J, Siafakas N. Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema. Thorax. 1994;49:852–855
  6. Bouros D, Schiza S, Tzanakis N, Drositis J, Siafakas N. Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema. Eur Respir J. 1996;9:1656–1659
  7. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med. 2004;170:49–53
  8. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352:865–874
  9. Bouros D, Antoniou KM, Light RW. Intrapleural streptokinase for pleural infection. BMJ. 2006;332:133–134
  10. Bouros D. A trial of intrapleural streptokinase. N Engl J Med. 2005;352:2243–2245[author reply-5]
  11. Ray TL, Berkenbosch JW, Russo P, Tobias JD. Tissue plasminogen activator as an adjuvant therapy for pleural empyema in pediatric patients. J Intensive Care Med. 2004;19:44–50
  12. Weinstein M, Restrepo R, Chait PG, Connolly B, Temple M, Macarthur C. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions. Pediatrics. 2004;113:e182–e185
  13. Wells RG, Havens PL. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology. 2003;228:370–378
  14. Idell S, Girard W, Koenig KB, McLarty J, Fair DS. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis. 1991;144:187–194
  15. Philip-Joet F, Alessi MC, Philip-Joet C, Aillaud M, Barriere JR, Arnaud A, et al. Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J. 1995;8:1352–1356
  16. Light RW. Parapneumonic effusions and empyema. Clin Chest Med. 1985;6:55–62
  17. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;52:416–421
  18. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med. 1997;155:291–295
  19. Gates RL, Hogan M, Weinstein S, Arca MJ. Drainage, fibrinolytics, or surgery: a comparison of treatment options in pediatric empyema. J Pediatr Surg. 2004;39:1638–1642
  20. Aelony Y. Parapneumonic effusion does not equal empyema. Chest. 1998;114:658–659
  21. Wiegand J, Tschopp JM, Froudarakis M, Tassi G, Brutsche M, ESMITTE Study Group . A randomized controlled study of early mini-invasive medical thoracoscopy vs simple chest tube drainage in complicated parapneumonic effusions or pleural empyema – ESMITTE (European study on mini-invasive thoracoscopy in empyema) – an intermediate report. Proc Am Thorac Soc. 2006;3:A540
  22. Kouliatsis G, Anevlavis S, Pataka A, Didilis V, Mikroulis D, Froudarakis ME, et al. Intrapleural tissue plasminogen activator vs VATS in loculated pleural infections. Proc Am Thorac Soc. 2006;3:A361
  23. Lee YCG. Ongoing search for effective intrapleural therapy for empyema: is streptokinase the answer?. Am J Respir Crit Care Med. 2004;170:1–2
  24. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest. 1997;111:275–279
  25. Moulton JS, Benkert RE, Weisiger KH, Chambers JA. Treatment of complicated pleural fluid collections with image-guided drainage and intracavitary urokinase. Chest. 1995;108:1252–1259
  26. Davies CW, Lok S, Davies RJ. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med. 1998;157:328–330
  27. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med. 1999;159:37–42
  28. Hua CC, Chang LC, Chen YC, Chang SC. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest. 1999;116:1292–1296
  29. Chung CL, Chen CH, Sheu JR, Chen YC, Chang SC. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates. Chest. 2005;128:690–697
  30. Park CS, Chung WM, Lim MK, Cho CH, Suh CH, Chung WK. Transcatheter instillation of urokinase into loculated pleural effusion: analysis of treatment effect. AJR Am J Roentgenol. 1996;167:649–652

PII: S0954-6111(08)00305-3

doi: 10.1016/j.rmed.2008.08.012

Respiratory Medicine
Volume 102, Issue 12 , Pages 1694-1700 , December 2008

Article Tools

* Image Usage & Resolution